Filing Details

Accession Number:
0001437749-20-024126
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-18 08:33:33
Reporting Period:
2020-11-16
Accepted Time:
2020-11-18 08:33:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1053691 Diffusion Pharmaceuticals Inc. DFFN Pharmaceutical Preparations (2834) 300645032
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1828068 Robert William Elder 1317 Carlton Avenue, Suite 200
Charlottesville VA 22902
Gc & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-16 10,000 $0.67 10,000 No 4 P Direct
Common Stock Acquisiton 2020-11-17 5,000 $0.63 15,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6492 to $0.6890, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.
  2. The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6234 to $0.6298, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.